Clinical trial

Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial

NCT00147264

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-04-01

PhasePHASE3

Study timeline

Study start (unknown)2004-04-01Date precision: month

Registry last updated2016-12-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metabolic Syndrome Xunresolved

Interventions

Telmisartan (Micardis®) vs. PlaceboDRUG

Low-Glycemic Index Diet vs. Control DietBEHAVIORAL

Sponsors & collaborators

McMaster Universitylead sponsor

Boehringer Ingelheimcollaborator

Canadian Institutes of Health Research (CIHR)collaborator

Heart and Stroke Foundation of Canadacollaborator

Medtroniccollaborator

Mapped research locations

HamiltonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00147264 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.